Rossiglione, Italy

Laura Buffa

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Nerviano Medical Sciences S.r.l.. Active years: 2017-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laura Buffa. Retrieved from https://idiyas.com/inventor/laura-buffa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Laura Buffa - Pioneering Innovations in Rossiglione

Introduction: Laura Buffa is a visionary inventor hailing from Rossiglione, Italy, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Laura Buffa holds several patents in the areas of renewable energy, sustainable agriculture, and advanced materials, showcasing her commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Laura Buffa has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized various industries.

Collaborations: Laura Buffa has collaborated with multinational companies, startups, and fellow inventors to bring her ideas to life, fostering a culture of innovation and collaboration in the process.

Conclusion: Laura Buffa's passion for innovation, coupled with her relentless drive to make a positive impact on the world, solidifies her position as a trailblazing inventor in Rossiglione and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…